Peer Review Journal Publication

Frontiers in Psychiatry have just published a peer review journal by the Transpharmation Ireland team, led by Jack Prenderville. ‘The Antidepressant-Like Effects of a Clinically Relevant Dose of Ketamine Are Accompanied by Biphasic Alterations in Working Memory in the Wistar Kyoto Rat Model of Depression.’ Major depressive disorder, (MDD) is the leading cause of disability worldwide. The majority of antidepressant drugs require several weeks or months of treatment to demonstrate efficacy and a subset of patients are resistant to such interventions. In this publication we examine depressive-like behavioural phenotypes in the Wistar-Kyoto rat model of depression, establish and demonstrate an effective clinically relevant dose of the novel therapeutic agent ketamine. Please read the full publication